Pharmacotherapy of pediatric and adolescent HIV infection
Susan J Schuval1,21Division of Allergy/immunology, Department of Pediatrics, North Shore – Long island Jewish Health System, Great Neck, NY, USA; 2Associate Professor of Clinical Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USAAbstract: Significant advances have been mad...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-06-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/pharmacotherapy-of-pediatric-and-adolescent-hiv-infection-a3273 |
| Summary: | Susan J Schuval1,21Division of Allergy/immunology, Department of Pediatrics, North Shore – Long island Jewish Health System, Great Neck, NY, USA; 2Associate Professor of Clinical Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USAAbstract: Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”, which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving. Keywords: antiretroviral, HAART, Pediatric Guidelines, HIV, AIDS |
|---|---|
| ISSN: | 1176-6336 1178-203X |